Aligos Therapeutics, Inc.
ALGS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$31,537 | -$15,863 | $43,088 | -$82,150 |
| Dep. & Amort. | $220 | $259 | $510 | $671 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,160 | $959 | $1,705 |
| Change in WC | $1,532 | $930 | -$3,835 | -$390 |
| Other Non-Cash | $5,440 | -$1,990 | -$61,631 | $61,761 |
| Operating Cash Flow | -$24,345 | -$15,504 | -$20,909 | -$18,403 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$193 | -$109 | -$43 | -$28 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$22,124 | -$39,312 | -$64,024 | $0 |
| Inv. Sales/Matur. | $70,000 | $0 | $20,000 | $20,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $47,683 | -$39,421 | -$44,067 | $19,972 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$10 | -$1 | $0 | -$43 |
| Stock Issued | -$43 | -$176 | $101,742 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $140 |
| Financing Cash Flow | -$53 | -$177 | $101,742 | $97 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $23,285 | -$55,102 | $36,766 | $1,666 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,771 | $73,873 | $37,107 | $35,441 |
| End Cash | $42,056 | $18,771 | $73,873 | $37,107 |
| Free Cash Flow | -$24,538 | -$15,613 | -$20,952 | -$18,431 |